Dow Down1.29% Nasdaq Down3.25%

More On ROSG


Rosetta Genomics, Ltd. (ROSG)

-NasdaqCM
0.89 Up 0.02(2.30%) Feb 5, 4:00PM EST
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
Total Revenue 1,327   405   201  
Cost of Revenue1,310  709  258  
Gross Profit 17   (304) (57)
Operating Expenses
Research Development1,927  1,744  1,247  
Selling General and Administrative12,342  11,299  6,963  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (14,252) (13,347) (8,267)
Income from Continuing Operations
Total Other Income/Expenses Net -   -   -  
Earnings Before Interest And Taxes(14,511)(13,170)(10,696)
Interest Expense -   -   -  
Income Before Tax(14,511)(13,170)(10,696)
Income Tax Expense15   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(14,526)(13,170)(10,696)
Non-recurring Events
Discontinued Operations -  273  239  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (14,526) (12,897) (10,457)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (14,526) (12,897) (10,457)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.